Minervax
0 followers
‌
Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.
Industries
+2
Headquarters
Employees
Links
Org chart
Per Fischer
Collapse
Bjørn Kantsø
CTO, Head of CMC
Ebbe Englev
Vice President Clinical Development
Karina Nymark
Vice President Clinical Operations
Msc Sten Verland
Chairman Audit Committee
Tina Biehl
Vice President Bioanalysis & Analytical Quality
Anders Fink V.
Interim Chief Financial Officer, Consulting Role
